Clinical Trial Update: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating palliative radiotherapy for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Second Primary Neoplasms

Snippet

Sponsor: University of Aarhus | Conditions: Head and Neck Neoplasms, Recurrence | Phase 2 | Status: COMPLETED